Genetic Engineering Market Research Reports & Industry Analysis
Genetic engineering is the deliberate modification of an organism's genetic material to achieve desired traits or outcomes, and it finds widespread applications in agriculture, medicine, and biotechnology. As genetic engineering continues to progress, it’s important to stay informed of the latest developments. MarketResearch.com offers a suite of genetic engineering industry reports that are designed to provide a comprehensive view of the industry.
Genetic Engineering Market Data
- Our collection of reports covers various aspects of genetic engineering markets, including genome editing, disease resistance, and herbicide tolerance.
- We provide in-depth analysis of genetic engineering market size, growth predictions, technology advancements, and the competitive landscape.
- Additionally, our reports explore disruptive trends that have the potential to reshape industries, helping you to stay ahead of the curve.
Using Knowledge to Inform Strategy
Whether you're an experienced industry expert, a consultant, or corporate executive, our genetic engineering market research reports provide the strategic insights you need to make informed decisions. These reports are based on reliable data, helping you not only keep up with competitors but also move forward with confidence. Browse our full list of genetic engineering reports here.
Genetic Engineering Industry Research & Market Reports
-
Plant Biotechnology - Company Evaluation Report, 2025 (Abridged Report)
... and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 140 companies, of which the Top 15 Plant Biotechnology Companies were categorized and recognized as quadrant leaders. The plant biotechnology market is a dynamic ... Read More
-
Microbiome Sequencing Service Market, By Service Type (6S rRNA gene profiling, Whole genome shotgun sequencing, Targeted gene sequencing, Single-cell sequencing, and Others), By Application (Gut microbiome analysis, Urinary microbiome analysis, and Others), By End User (Academic and research institutes, Pharmaceutical and Biotechnology companies, Diagnostic laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... sequencing technologies to study the microbial communities within and associated with the human body. The human microbiome refers to the genomes of all microorganisms that reside on or within bodies. Advances in next-generation sequencing technologies ... Read More
-
Biohacking Market, By Type (Inside and Outside), By Product (Smart Drugs, Sensors, Strains, Others), By Application (Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis & Treatment, Drug Testing), By End User (Biopharmaceutical Companies, Forensic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... hacking techniques such as quantifying health, gene editing, microbiome manipulation, and cognitive enhancements. Growing interest among people to take control of their health and optimize human performance through novel bio-enabled technologies boosts demand for biohacking ... Read More
-
The 2026-2031 World Outlook for Microbiome Sequencing by Synthesis Services
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Microbiome Therapeutics for Type 2 Diabetes
... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More
-
The 2026-2031 World Outlook for Microbiome Sequencing
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Microbiome Therapeutics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Microbiome Sequencing Services
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Bioengineered Protein Drugs
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Human Microbiomes
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Human Microbiome Therapeutics
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Human Microbiome Studies and Treatments for Acute Diarrhea
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
2025 Global Forecast for Human Genetics Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Animal Genetics
... CAGR of 5.8% over the analysis period 2024-2030. Live Animals, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$7.3 Billion by the end of the analysis ... Read More
-
Bioengineered Protein Drugs
... at a CAGR of 4.2% over the analysis period 2024-2030. Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$129.2 Billion by the end of ... Read More
-
DNA Polymerase
... CAGR of 0.8% over the analysis period 2024-2030. Taq Polymerase, one of the segments analyzed in the report, is expected to record a 0.6% CAGR and reach US$66.1 Million by the end of the analysis ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Polymers and Biopolymers in Beauty and Personal Care Products
... the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Conditioning, one of the segments analyzed in the report, is expected to record ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Microbiome Therapeutics
... CAGR of 56.8% over the analysis period 2024-2030. C. Difficile Infection, one of the segments analyzed in the report, is expected to record a 53.0% CAGR and reach US$7.3 Billion by the end of the ... Read More
-
DNases, Ligases, and RNA Polymerases
... Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Biopharmaceutical Processing Application, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$840.7 ... Read More
-
Plant Genomics
... CAGR of 8.0% over the analysis period 2024-2030. Molecular Engineering, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.5 Billion by the end of the analysis ... Read More
-
Plant Biotechnology Equipment
... at a CAGR of 14.2% over the analysis period 2024-2030. Breeding, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$25.6 Billion by the end of the ... Read More
-
Enzymatic DNA Synthesis Market Size, Share & Trends Analysis Report By Service (Oligonucleotide Synthesis, Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering), By End-use, By Region, And Segment)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... growing at a CAGR of 26.5% from 2024 to 2033. Enzymatic DNA Synthesis Market Key Takeaways North America dominated the market and accounted for a 50.81% share in 2023 The enzymatic DNA synthesis market in ... Read More
-
Innovative Medicine Market, By Therapy Type (Immunotherapy, Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule Therapy, Biologic Therapy, RNA-Based Therapy, Progenitor Cell Therapy, Peptide-Based Therapy, Microbiome Therapy, Antisense Oligonucleotide Therapy, CRISPR-based Therapy, mRNA-based Vaccines, and Monoclonal Antibodies), By Application (Oncology, Neurology, Cardiology, Ophthalmology, Dermatology, Musculoskeletal Disorders, Immunology & Inflammation, Genetic Disorders, Infectious Diseases, Metabolic Disorders, Hematology, Rare Diseases, Gastroenterology, and Others), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular, Topical, and Inhalation), By End User (Hospitals & Clinics, Academic & Research Institutes, Specialty Centers, Ambulatory Surgical Centers, Government & Regulatory Bodies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Innovative medicines, also known as specialty drugs or biopharmaceuticals, are advanced medical treatments that offer new and improved therapeutic options for various diseases. These medicines are developed using cutting-edge technologies and are designed to target ... Read More
Research Assistance
